Riskpilot← Back to searchSign inGet full accessHansen & Ingman AB
ABActiveOrg 5567763296Skredsviks Anneröd 320Physiotherapy activities · NACE 8695Est. 20091 employees
Revenue 2025
SEK 715K
-42% vs 2024
EBITDA margin
3.2%
-70% vs 2024
Equity ratio
71.0%
Financial strength
Net profit 2025
SEK 79K
-53% vs 2024
| Revenue | SEK 715K | -42% |
| EBITDA | SEK 23K | -70% |
| Net profit | SEK 79K | -53% |
| Total assets | SEK 710K | -35% |
| Equity | SEK 504K | -30% |
| Employees | 1 | — |
Legal name
Hansen & Ingman AB
Org number
5567763296
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
19 januari 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva medicinsk konsultverksamhet, rehabilitering, omvårdnad, socialt omhändertagande, hälso- samt friskvård samt konsultverksamhet inom dessa områden, byggprojektsamordning samt genomförande, värdepappershantering, fastighets- och egendomshantering och förvaltning samt därmed förenlig verksamhet.
Address
Skredsviks Anneröd 320
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 583 | 1 373 | 1 213 | 1 237 | 715 |
| Staff expenses | — | — | −985 | −1 024 | −595 |
| EBITDA | 551 | 395 | 104 | 75 | 23 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 551 | 395 | 104 | 75 | 23 |
| Net financials | — | — | 4 | 64 | 2 |
| Profit before tax | 550 | 395 | 308 | 214 | 99 |
| Tax | −123 | −82 | −67 | −46 | −21 |
| Net profit | 427 | 313 | 241 | 168 | 79 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 275 | 1 429 | 1 260 | 1 094 | 710 |
| Equity | 674 | 797 | 848 | 726 | 504 |
| Long-term debt | 179 | 182 | 172 | 172 | 172 |
| Short-term debt | 73 | 100 | 90 | 121 | 34 |
| Total debt | 252 | 282 | 262 | 293 | 206 |
EBITDA margin
3.2%
This company
15.8%
Market median
-80% vs market
20212025
Equity ratio
71.0%
This company
38.2%
Market median
+86% vs market
20212025
Return on equity
15.6%
This company
18.4%
Market median
+15% vs market
20212025
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20212025
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
20212025
Debt / equity
0.41×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hansen & Ingman AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gerald Stephan Günther Hansen | Board of Directors | 0 companies |
| Åsa Maria Ingman | Deputy Board Member | 0 companies |